Volume | 35,077 |
|
|||||
Noticias | (1) | ||||||
Máximo del Dia | 5.43 | Mínimo Máximo |
|||||
Minimo del Dia | 4.85 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Orchestra BioMed Holdings Inc | OBIO | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
5.26 | 4.85 | 5.43 | 5.31 | 5.22 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
428 | 35,077 | US$ 5.23 | US$ 183,613 | - | 4.22 - 17.35 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
15:01:58 | priorref | 370 | US$ 5.30 | USD |
Información Financiera Orchestra BioMed Holdings Inc OBIO
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
189.8M | 35.74M | - | 2.76M | -49.12M | -1.37 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Orchestra BioMed Holdings Inc OBIO
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
24/5/2024 | 15:16 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
13/5/2024 | 15:38 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
10/5/2024 | 16:25 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
10/5/2024 | 16:24 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
10/5/2024 | 16:23 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
10/5/2024 | 16:18 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
09/5/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
09/5/2024 | 16:04 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
19/9/2023 | 09:19 | Dow Jones News | Orchestra BioMed Shares Jump on FDA Nod for BackBeat Study |
19/9/2023 | 07:24 | Dow Jones News | Orchestra BioMed Gets FDA Nod for BackBeat Study |
Histórico de Datos OBIO
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 4.68 | 5.5599 | 4.68 | 5.20 | 30,185 | 0.63 | 13.46% |
1 Month | 4.42 | 5.56 | 4.29 | 4.88 | 33,756 | 0.89 | 20.14% |
3 Months | 6.54 | 7.25 | 4.22 | 5.17 | 39,597 | -1.23 | -18.81% |
6 Months | 6.10 | 11.69 | 4.22 | 7.02 | 51,359 | -0.79 | -12.95% |
1 Year | 14.83 | 17.35 | 4.22 | 7.78 | 83,494 | -9.52 | -64.19% |
3 Years | 11.75 | 23.39 | 4.22 | 9.15 | 78,408 | -6.44 | -54.81% |
5 Years | 11.75 | 23.39 | 4.22 | 9.15 | 78,408 | -6.44 | -54.81% |